GlassScriptPhysician profile
Athos Patsalides
NPI 1447409164
$32,387.67
in general payments reported to CMS, 2019-2025
13 companies · $3,200 in 2025
The $3,200 reported for 2025 was more than what 78% of Neuroradiology providers received nationally (typical 2025 total: $278).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $332 · 2021: $4,762 · 2022: $4,946 · 2023: $1,138 · 2024: $1,177 · 2025: $3,200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,141 · Consulting Fee: $2,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,141.43 |
| Consulting Fee | $2,375.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microvention, INC. | $12,975.69 | 2019-2023 | Web Aneurysm Embolization System, Hydrosoft Advanced |
| Penumbra, INC. | $12,211.45 | 2019-2025 | Red 72, Penumbra System, Benchmark |
| Balt USA, LLC | $2,866.71 | 2022-2025 | Ballast 088 Long Sheath, Raptor Aspiration Catheter, Carrier Delivery Catheter |
| Qapel Medical INC | $1,583.07 | 2022-2025 | |
| Stryker Corporation | $1,377.56 | 2019-2025 | Universal Neuro 3, Broadway 8, Axs Vecta 71 |
| Medtronic, INC. | $667.83 | 2022-2025 | Pipeline, Solitaire X |
| Medtronic USA, INC. | $432.16 | 2019 | |
| Cordis US Corp. | $103.63 | 2021-2025 | Precise Pro Rx, Mynx Control Venous |
| Depuy Synthes Sales INC. | $56.78 | 2019 | |
| Phenox INC. | $47.10 | 2020 | |
| Inspiremd LTD | $34.03 | 2025 | Cguard Prime Carotid Stent System |
| Route 92 Medical, INC. | $31.66 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Athos Patsalides listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.